We are live on ! Find out more
KDNY

Chinook Therapeutics, Inc. Common Stock
KDNY

Delisted

KDNY was delisted on the 10th of August, 2023.

Back to rankings

82 hedge funds and large institutions have $301M invested in Chinook Therapeutics, Inc. Common Stock in 2017 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 42 increasing their positions, 20 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

586% more call options, than puts

Call options by funds: $803K | Put options by funds: $117K

110% more repeat investments, than reductions

Existing positions increased: 42 | Existing positions reduced: 20

12% more capital invested

Capital invested by funds: $270M → $301M (+$31.2M)

0% more funds holding

Funds holding: 82 → 82 (0)

0% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 12

Holders
82
Holders Change
–
Holders Change %
0%
% of All Funds
2.04%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
12
Increased
42
Reduced
20
Closed
12
Calls
$803K
Puts
$117K
Net Calls
+$686K
Net Calls Change
-$117K

Top Buyers

Rank Fund Capital Flow
1
O
OppenheimerFunds
New York
+$8.19M
2
BI
BVF Inc
California
+$3.01M
3
JP Morgan Chase
JP Morgan Chase
New York
+$2.76M
4
BlackRock
BlackRock
New York
+$2.29M
5
Wellington Management Group
Wellington Management Group
Massachusetts
+$2.27M

Top Sellers

Rank Fund Capital Flow
1
GTC
Ghost Tree Capital
New York
-$8.6M
2
CCP
Clough Capital Partners
Massachusetts
-$3.21M
3
Fidelity Investments
Fidelity Investments
Massachusetts
-$2.54M
4
Balyasny Asset Management
Balyasny Asset Management
Illinois
-$845K
5
Citadel Advisors
Citadel Advisors
Florida
-$633K
Name Holding Trade Value Shares
Change 		Change in
Stake
CM
26
Crestline Management
Texas
$1.25M +$390K +7,770 +55%
VIA
27
Vident Investment Advisory
Georgia
$1.22M +$281K +5,602 +35%
TCIM
28
TIAA CREF Investment Management
New York
$1.21M +$77.4K +1,542 +8%
AG
29
Artal Group
Luxembourg
$1.14M – – –
Jennison Associates
30
Jennison Associates
New York
$909K -$46.4K -925 -5%
TA
31
Teachers Advisors
New York
$826K +$122K +2,431 +20%
California State Teachers Retirement System (CalSTRS)
32
California State Teachers Retirement System (CalSTRS)
California
$823K -$14.1K -280 -2%
AA
33
ALPS Advisors
Colorado
$719K +$53.3K +1,062 +9%
Millennium Management
34
Millennium Management
New York
$627K -$243K -4,840 -31%
New York State Common Retirement Fund
35
New York State Common Retirement Fund
New York
$584K +$90.3K +1,800 +21%
Swiss National Bank
36
Swiss National Bank
Switzerland
$573K +$118K +2,360 +31%
PP
37
PDT Partners
New York
$570K +$502K +10,000 New
AllianceBernstein
38
AllianceBernstein
Tennessee
$528K +$52.2K +1,040 +13%
RhumbLine Advisers
39
RhumbLine Advisers
Massachusetts
$512K +$54.3K +1,082 +14%
ProShare Advisors
40
ProShare Advisors
Maryland
$450K -$4.57K -91 -1%
DekaBank Deutsche Girozentrale
41
DekaBank Deutsche Girozentrale
Germany
$414K +$363K +7,240 New
Russell Investments Group
42
Russell Investments Group
United Kingdom
$408K +$359K +7,154 New
Wells Fargo
43
Wells Fargo
California
$392K +$104K +2,075 +43%
Manulife (Manufacturers Life Insurance)
44
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$388K +$37.8K +754 +12%
State of Wisconsin Investment Board
45
State of Wisconsin Investment Board
Wisconsin
$353K +$311K +6,200 New
PCM
46
Piermont Capital Management
Missouri
$351K -$51.2K -1,020 -14%
PPA
47
Parametric Portfolio Associates
Washington
$321K +$127K +2,540 +82%
VEA
48
Virtus ETF Advisers
New York
$318K +$23.3K +464 +9%
MLICM
49
Metropolitan Life Insurance Company (MetLife)
New York
$307K – – –
HCM
50
Highbridge Capital Management
New York
$294K -$538K -10,713 -68%
1
2
3 4

KDNY Hedge Fund Activity: Q2 2017 in Review

82 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Chinook Therapeutics, Inc. Common Stock (KDNY) for Q2 2017, worth a combined $301M — up 12% from $270M a quarter earlier.

Fund positioning in KDNY was balanced in Q2 2017: 12 funds opened new positions, 12 closed out, 42 added to existing stakes and 20 trimmed.

The largest buyer was OppenheimerFunds, opening a new position worth an estimated $8.19M. The largest seller was Ghost Tree Capital, exiting entirely with an estimated $8.6M sold.

  • 82 institutional investors held Chinook Therapeutics, Inc. Common Stock (KDNY) as of Q2 2017, unchanged from Q1 2017.
  • Funds reported $301M of Chinook Therapeutics, Inc. Common Stock stock for Q2 2017, up 12% quarter-over-quarter.
  • 12 funds opened new Chinook Therapeutics, Inc. Common Stock positions in Q2 2017 and 12 closed out, a net change of 0 holders.
  • The largest Chinook Therapeutics, Inc. Common Stock buyer in Q2 2017 was OppenheimerFunds, an estimated $8.19M added.
  • The largest Chinook Therapeutics, Inc. Common Stock seller in Q2 2017 was Ghost Tree Capital, an estimated $8.6M sold.

Based on aggregated 13F filings for Q2 2017.